Your browser doesn't support javascript.
Nosocomial infections amongst critically ill COVID-19 patients in Australia.
Ramanan, Mahesh; Burrell, Aidan; Paul, Eldho; Trapani, Tony; Broadley, Tessa; McGloughlin, Steve; French, Craig; Udy, Andrew.
  • Ramanan M; Caboolture Hospital, 120 McKean Street, Caboolture, Queensland, Australia.
  • Burrell A; Critical Care Division, The George Institute for Global Health, University of New South Wales, 1 King Street, Newtown, New South Wales, 2042, Australia.
  • Paul E; School of Medicine, University of Queensland, St. Lucia, Queensland, 4072, Australia.
  • Trapani T; Department of Epidemiology and Preventative Medicine, School of Public Health, Monash University, Melbourne, Australia.
  • Broadley T; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, 553St Kilda Road, Melbourne, Victoria, Australia.
  • McGloughlin S; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, 553St Kilda Road, Melbourne, Victoria, Australia.
  • French C; Department of Epidemiology and Preventative Medicine, School of Public Health, Monash University, Melbourne, Australia.
  • Udy A; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, 553St Kilda Road, Melbourne, Victoria, Australia.
J Clin Virol Plus ; 1(4): 100054, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1734706
ABSTRACT

Purpose:

To determine the frequency of nosocomial infections including hospital-acquired pneumonia (HAP) and bloodstream infection (BSI), amongst critically ill patients with COVID-19 infection in Australian ICUs and to evaluate associations with mortality and length of stay (LOS).

Methods:

The effect of nosocomial infections on hospital mortality was evaluated using hierarchical logistic regression models to adjust for illness severity and mechanical ventilation.

Results:

There were 490 patients admitted to 55 ICUs during the study period. Adjusted odds ratio (OR) for hospital mortality was 1.61 (95% confidence interval (CI) 0.61-4.27, p = 0.3) when considering BSI, and 1.76 (95% CI 0.73-4.21, p = 0.2) for HAP. The average adjusted ICU LOS was significantly longer for patients with BSI (geometric mean 9.0 days vs 6.3 days, p = 0.04) and HAP (geometric mean 13.9 days vs 6.0 days p<0.001).

Conclusion:

Nosocomial infection rates amongst patients with COVID-19 were low and their development was associated with a significantly longer ICU LOS.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: J Clin Virol Plus Year: 2021 Document Type: Article Affiliation country: J.jcvp.2021.100054

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: J Clin Virol Plus Year: 2021 Document Type: Article Affiliation country: J.jcvp.2021.100054